AAAAAA

   
Results: 1-16 |
Results: 16
Cardiac transplant outcome of patients supported on left ventricular assist device vs intravenous inotropic therapy
Authors: Jaski, BE Kim, JC Naftel, DC Jarcho, J Costanzo, MR Eisen, HJ Kirklin, JK Bourge, RC
Citation: Be. Jaski et al., Cardiac transplant outcome of patients supported on left ventricular assist device vs intravenous inotropic therapy, J HEART LUN, 20(4), 2001, pp. 449-456
P-31-magnetic resonance spectroscopy studies of cardiac transplant patients at rest
Authors: Buchthal, SD Noureuil, TO den Hollander, JA Bourge, RC Kirklin, JK Katholi, CR Caulfield, JB Pohost, GM Evanochko, WT
Citation: Sd. Buchthal et al., P-31-magnetic resonance spectroscopy studies of cardiac transplant patients at rest, J CARD M RE, 2(1), 2000, pp. 51-56
Psychological defensiveness among heart transplant candidates
Authors: Williams, MA Putzke, JD LaMarche, JA Bourge, RC Kirklin, JK McGiffin, DC Boll, TJ
Citation: Ma. Williams et al., Psychological defensiveness among heart transplant candidates, J CL P MED, 7(3), 2000, pp. 167-174
Self-report versus performance-based activities of daily living capacity among heart transplant candidates and their caregivers
Authors: Putzke, JD Williams, MA Daniel, FJ Bourge, RC Boll, TJ
Citation: Jd. Putzke et al., Self-report versus performance-based activities of daily living capacity among heart transplant candidates and their caregivers, J CL P MED, 7(2), 2000, pp. 121-132
Cost-benefit analysis of extended antifungal prophylaxis in ventricular assist devices
Authors: Skinner, JL Harris, C Aaron, MF McGiffin, DC Kirklin, JK Bourge, RC Holman, WL
Citation: Jl. Skinner et al., Cost-benefit analysis of extended antifungal prophylaxis in ventricular assist devices, ASAIO J, 46(5), 2000, pp. 587-589
Activities of daily living among heart transplant candidates: Neuropsychological and cardiac function predictors
Authors: Putzke, JD Williams, MA Daniel, FJ Bourge, RC Boll, TJ
Citation: Jd. Putzke et al., Activities of daily living among heart transplant candidates: Neuropsychological and cardiac function predictors, J HEART LUN, 19(10), 2000, pp. 995-1006
Echocardiographic diagnosis of a stenotic double orifice parachute mitral valve with a single papillary muscle
Authors: Yesilbursa, D Miller, A Nanda, NC Mukhtar, O Huang, WY Ansingkar, K Puri, V Bourge, RC Hsiung, M McGiffin, DC
Citation: D. Yesilbursa et al., Echocardiographic diagnosis of a stenotic double orifice parachute mitral valve with a single papillary muscle, ECHOCARDIOG, 17(4), 2000, pp. 349-352
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure.
Authors: Colucci, WS Elkayam, U Horton, DP Abraham, WT Bourge, RC Johnson, AD Wagoner, LE Givertz, MM Liang, CS Neibaur, M Haught, WH
Citation: Ws. Colucci et al., Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure., N ENG J MED, 343(4), 2000, pp. 246-253
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease - A randomized, controlled trial
Authors: Badesch, DB Tapson, VF McGoon, MD Brundage, BH Rubin, LJ Wigley, FM Rich, S Barst, RJ Barrett, PS Kral, KM Jobsis, MM Loyd, JE Murali, S Frost, A Girgis, R Bourge, RC Ralph, DD Elliott, CG Hill, NS Langleben, D Schilz, RJ McLaughlin, VV Robbins, IM Groves, BM Shapiro, S Medsger, TA Gaine, SP Horn, E Decker, JC Knobil, K
Citation: Db. Badesch et al., Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease - A randomized, controlled trial, ANN INT MED, 132(6), 2000, pp. 425
Biventricular pacing for congestive heart failure: Questions of who, what,where, why, how, and how much
Authors: Kay, GN Bourge, RC
Citation: Gn. Kay et Rc. Bourge, Biventricular pacing for congestive heart failure: Questions of who, what,where, why, how, and how much, AM HEART J, 140(6), 2000, pp. 821-823
Rationale and design of the OPTIME CHF trial: Outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure
Authors: Cuffe, MS Califf, RM Adams, KF Bourge, RC Colucci, W Massie, B O'Connor, CM Pina, I Quigg, R Silver, M Robinson, LA Leimberger, JD Gheorghiade, M
Citation: Ms. Cuffe et al., Rationale and design of the OPTIME CHF trial: Outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure, AM HEART J, 139(1), 2000, pp. 15-22
Nonpharmacologic validation of the intrinsic heart rate in cardiac transplant recipients
Authors: Strobel, JS Epstein, AE Bourge, RC Kirklin, JK Kay, GN
Citation: Js. Strobel et al., Nonpharmacologic validation of the intrinsic heart rate in cardiac transplant recipients, J INTERV C, 3(1), 1999, pp. 15-18
Selection and evaluation of patients for cardiac transplantation
Authors: Castro, PF Bourge, RC Jalil, JE Martinez, JA
Citation: Pf. Castro et al., Selection and evaluation of patients for cardiac transplantation, REV ESP CAR, 52(8), 1999, pp. 604-616
Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: A randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine - Results at six months after transplantation
Authors: Eisen, HJ Hobbs, RE Davis, SF Laufer, G Mancini, DM Renlund, DG Valantine, H Ventura, H Vachiery, JL Bourge, RC Canver, CC Carrier, M Costanzo, MR Copeland, J Dureau, G Frazier, OH Dorent, R Hauptman, PJ Kells, C Masters, R Michaud, JL Paradis, I Smith, A Vanhaecke, J Feutren, G Turkin, D Mellein, B Mueller, EA
Citation: Hj. Eisen et al., Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: A randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine - Results at six months after transplantation, TRANSPLANT, 68(5), 1999, pp. 663-671
Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension
Authors: Langleben, D Barst, RJ Badesch, D Groves, BM Tapson, VF Murali, S Bourge, RC Ettinger, N Shalit, E Clayton, LM Jobsis, MM Blackburn, SD Crow, JW Stewart, DJ Long, W
Citation: D. Langleben et al., Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension, CIRCULATION, 99(25), 1999, pp. 3266-3271
A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure
Authors: Cohn, JN Goldstein, SO Greenberg, BH Lorell, BH Bourge, RC Jaski, BE Gottlieb, SO McGrew, F DeMets, DL White, BG
Citation: Jn. Cohn et al., A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure, N ENG J MED, 339(25), 1998, pp. 1810-1816
Risultati: 1-16 |